You committed to bringing ‘radical transparency’ to the Department of Health and Human Services (HHS), but your ongoing refusal to release these deals raises questions about whether the Trump administration is trying to hide the fact that it is giving billion-dollar handouts to Big Pharma without getting anything meaningful in return for Americans.
Addressing Robert F. Kennedy Jr. about drug pricing deals.
Share
More from Elizabeth Warren
The appearance of numerous conflicts of interest from a President trading in individual stocks – including the potential for insider trading, market manipulation, and policy decisions that benefit the President’s stock portfolio rather…
Removing these reports appears to be an attempt to avoid disclosure of information the public needs to evaluate if major, high-dollar weapon systems are effective and safe.
We need to ensure that these tariff refunds benefit American consumers, not just corporations.
Other voices in this conversation
